Cargando…
Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis”
Autores principales: | Teklu, Meron, Chung, Hye Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684363/ https://www.ncbi.nlm.nih.gov/pubmed/38034367 http://dx.doi.org/10.1016/j.jdcr.2023.09.038 |
Ejemplares similares
-
Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis
por: Pope, Eleanor, et al.
Publicado: (2022) -
Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis
por: Piquero-Casals, Jaime, et al.
Publicado: (2019) -
Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment
por: Kim, Hye One, et al.
Publicado: (2015) -
Topical ruxolitinib for the treatment of granuloma faciale
por: Wong, Alan, et al.
Publicado: (2023) -
Effectiveness of traditional Chinese medicine preparations for facial seborrheic dermatitis: case reports
por: Zhang, Ruifeng, et al.
Publicado: (2022)